KMID : 1001020200180020147
|
|
Journal of Urologic Oncology 2020 Volume.18 No. 2 p.147 ~ p.154
|
|
Potential Utility of Prostate Health Index Density for Prostate Cancer Detection and Prediction in Korean Men: A Prospective Multicenter Study
|
|
Song Gee-Hyun
Park Hong-Zoo Lee Sang-Wook Kang Tae-Wook Jung Jae-Hung Chung Hyun-Chul Kim Sung-Jin Park Jong-Yeon Kim Jeong-Hyun
|
|
Abstract
|
|
|
Purpose: We evaluated the clinical performance of Prostate Health Index (PHI) density with [-2]proPSA (p2PSA) and its derivatives in predicting the presence of prostate cancer (PCa) in Korean men.
Materials and Methods: A total of 706 men with total prostate-specific antigen (tPSA)¡Ã2.5 ng/mL who underwent their first prostate biopsy were included in this prospective, multicenter, observational study. Diagnostic accuracy of tPSA, free-to-total PSA ratio (%fPSA), p2PSA, %p2PSA, the Beckman Coulter PHI, and PHI density was assessed by receiver operating characteristic curve analyses and logistic regression analyses. PHI was calculated as [(p2PSA/free PSA)¡¿tPSA¨ö], and density calculations were performed using prostate volume as determined by transrectal ultrasonography.
Results: Overall, PCa was detected in 367 of all subjects (52%). In men with tPSA 2.5?10 ng/mL, the detection rate of PCa was 41.1% (188 of 457). In this group, PHI and PHI density were the most accurate predictors of PCa and significantly outperformed tPSA and %fPSA; area under the curve for tPSA, %fPSA, %p2PSA, PHI, and PHI density was 0.58, 0.68, 0.70, 0.75, 0.73 respectively. PHI and PHI density were also the strongest predictor of PCa with Gleason score ¡Ã7.
Conclusions: Based on the present prospective multicenter experience, PHI and PHI density demonstrate the superior clinical performance in predicting the presence of PCa in Korean men with tPSA 2.5?10 ng/mL.
|
|
KEYWORD
|
|
Biomarkers, Biopsy, Early diagnosis, , Prostatic cancer, Prostate-specific antigen, Protein isoforms
|
|
FullTexts / Linksout information
|
|
|
|
Listed journal information
|
|
|
|